Skip to content

The effect of remimazolam mesylate and propofol on postoperative delirium in very elderly patients: A randomized controlled study

The effect of remimazolam mesylate and propofol on postoperative delirium in very elderly patients: A randomized controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500108468
Enrollment
Unknown
Registered
2025-09-01
Start date
2025-09-01
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

none

Interventions

Remimazolam mesylate group:The remimazolam mesylate group was sedated with remimazolam mesylate
propofol group:The propofol group was sedated with propofol

Sponsors

Wusheng County People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
80 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Extremely elderly patients aged 80 or above; 2. ASA classification grades I to IV; 3. Elective surgery is scheduled, and the operation time is no more than 3 hours. 4.18 kg/m ² <= body mass index (BMI) <=28 kg/m ².

Exclusion criteria

Exclusion criteria: 1. Preoperative complications of severe heart, lung, liver and kidney diseases (such as Child-Pugh grade C, cardiac function grade IV); 2. History of severe neuropsychiatric disorders (such as epilepsy, schizophrenia); 3. History of alcohol or drug dependence (such as benzodiazepines).

Design outcomes

Primary

MeasureTime frame
The incidence of postoperative delirium;

Secondary

MeasureTime frame
Heart rate (HR), mean arterial pressure (MAP), and BIS values;Total incidence of adverse events;IL-1ß and TNF-a levels;

Countries

China

Contacts

Public ContactTan Xingwen

Wusheng County People's Hospital

993472310@qq.com+86 156 3219 3453

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026